From Molecule to Market

MZPC is a broad-based pharmaceutical and fine chemical company that manufactures through a global network of FDA inspected and cGMP compliant partner manufacturing plants.  MZPC provides clients and partners with active pharmaceutical ingredients (API’s), finished dosage forms, injectables, contract manufacturing services, process development and optimization, regulatory services, clinical services from cGMP and FDA inspected facilities. MZPC and our clients and partners have established a tremendous reputation and are recognized for high quality products and performance efficacy.

MZPC has been a key supplier to the North American pharmaceutical market since 1973 and was the API supplier in the first Paragraph IV challenge and continues to be very active in many Paragraph IV and ANDA filings today.  To complement this core activity, MZPC established a generic division to work closely with customers and partners to bring approved ANDAs to market.

Over the years, MZPC has assisted pharmaceutical and biotech companies develop new molecules and optimize process’s which lead to our successful approval and launch of a new product in Japan in 2009, followed by Europe and the USA in 2014.  We have more molecules in advance stages of clinical testing.

Our global team of seasoned professional will work with you to establish a mutually beneficial relationship. We will be there from start to finish every step of the way, from Molecule to Market.  Our reputation is based on your success.